Log In
Print
BCIQ
Print
Print this Print this
 

PRO135

  Manage Alerts
Collapse Summary General Information
Company Prosensa Holding N.V.
DescriptionRNA-based antisense oligonucleotide
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPreclinical
Standard IndicationMyotonic dystrophy type 1 (DM1)
Indication DetailsTreat myotonic dystrophy type 1 (DM1)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today